Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
2
institutions
Market cap
$135.5B
2,160M shares
52-week range
$46.38 – $67.30
74% from low
Exchange
NYSE
ADRC
Borrow rate
0.25%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $24.49B | $25.88B | $25.78B | $25.68B | $27.66B | $27.28B | $25.87B | $25.61B |
| Cost of revenue | $4.60B | $4.46B | $4.45B | $4.60B | $4.80B | $4.89B | $4.44B | $4.23B |
| Gross profit | $19.89B | $21.42B | $21.33B | $21.09B | $22.85B | $22.39B | $21.43B | $21.38B |
| Gross margin | 81.2% | 82.8% | 82.7% | 82.1% | 82.6% | 82.1% | 82.9% | 83.5% |
| R&D | $105.0M | $376.0M | $307.0M | $304.0M | $323.0M | $408.0M | $380.0M | $133.0M |
| Operating income | $10.03B | $10.41B | $9.96B | $10.23B | $10.52B | −$15.75B | $2.74B | $10.00B |
| EBITDA | $10.53B | $10.06B | $11.78B | $11.19B | $12.23B | $13.28B | $7.74B | $11.76B |
| Net income | $6.03B | $5.70B | $6.40B | $6.80B | $6.67B | −$14.37B | $3.07B | $7.76B |
| Net margin | 24.6% | 22.0% | 24.8% | 26.5% | 24.1% | -52.7% | 11.9% | 30.3% |
| EPS (diluted) | 2.66 | 2.49 | 2.79 | 2.96 | 2.92 | -6.47 | 1.36 | 3.49 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $26.1B | $3.57 | $3.46–$3.63 | 4 |
| 2027 | $27.0B | $3.85 | $3.73–$3.91 | 4 |
| 2028 | $28.0B | $4.18 | $4.08–$4.26 | 3 |
| 2029 | $29.0B | $4.50 | $4.39–$4.58 | 2 |
Forward consensus · source: Financial Modeling Prep
The third-largest tobacco company by volume, British American Tobacco sold 465 billion cigarettes in 2025. Its leading brands are Dunhill, Kent, Pall Mall, Lucky Strike, and Rothmans in cigarettes. Its ownership of the Camel, Natural American Spirit, and Newport brands are limited to the US. In next-generation products, the company has the Vuse brand in vaping, Glo in heated tobacco, and Velo in modern oral tobacco. The company also owns a 22.9% stake in ITC limited, the largest Indian cigarette company.
www.bat.comNo one on the platform currently holds BTI.
| Institution | Shares | Reported |
|---|---|---|
| Bridgewater Associatesas of 2026-03-31 | 765,848 | $44.8M |
| Renaissance Technologiesas of 2026-03-31 | 581,299 | $34.0M |
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-12-29 | $0.8349 | 2027-02-08 |
| 2026-10-02 | $0.8349 | 2026-11-12 |
| 2026-07-10 | $0.8349 | 2026-08-19 |
| 2026-03-27 | $0.8340 | 2026-05-12 |
| 2025-12-30 | $0.8234 | 2026-02-09 |
| 2025-10-03 | $0.7491 | 2025-11-13 |
| 2025-06-27 | $0.7974 | 2025-08-06 |
| 2025-03-28 | $0.8022 | 2025-05-12 |
| 2024-12-20 | $0.7304 | 2025-02-06 |
| 2024-09-27 | $0.7627 | 2024-11-06 |
No one on the platform has traded BTI yet.
| -0.77% |
| $94.8B |
| — |
| MOAltria Group, Inc. | $72.57 | -2.00% | $121.2B | — |
| PMPhilip Morris International Inc. | $180.82 | -1.12% | $281.8B | — |
Source: Financial Modeling Prep · peers by sector/industry
| 2024-06-28 | $0.7538 | 2024-08-07 |
| 2024-03-21 | $0.7349 | 2024-05-07 |
| Execution date | Ratio |
|---|---|
| 2017-02-14 | 2-for-1 |
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
$BTI (-1.2% pre) British American Tobacco cost-cutting hits 9,000 roles https://ooc.bz/l/106428
View on StockTwits ↗British American Tobacco’s Job Cuts Draw Investor Buzz – Certain Roles To Be Outsourced To Partners In AI Adoption Push $BTI https://stocktwits.com/news/equity/markets/british-american-tobacco-s-job-cuts-draw-investor-buzz-certain-roles-to-be-outsourced-to-partners-in-ai-adoption-push/cZ193fAR7hj
View on StockTwits ↗$BTI hate I missed that $58-59 price level that was my entry
View on StockTwits ↗$ADBE reminds Me of bagholding on $T $INTC and $BTI I think this is the pivot point for a slow climb to ATH
View on StockTwits ↗🟢 $BTI 65C Sep 18 🚨 REPEAT SWEEP 💰 $34K · $1.7/contract · 0.4x Vol/OI 📍 Spot $61.49 BTI sweep #5 targets $66.70 breakeven in 86 DTE, $34K added to prior $30K positioning as buyer pays ask for 8.5% upside from $61.49.
View on StockTwits ↗Following up on my Big Tobacco's combustible decline post above, I looked at $BTI, $PM, and $MO balance sheets, all three carry significant net debt (combined ~$98B in debt vs ~$13B cash), but PM alone generated $12B+ in operating cash flow last year. Capital for a deal exists if the strategic case is there. However, one name I don't see discussed enough: Japan Tobacco. They have been historically underweight in the US market but they've already shown they're willing to write a check to fix that, acquiring Vector Group (Liggett) for $2.4B in 2024. A company with JT's track record and US ambition is exactly the type that could find CHUC's PMTA portfolio and age-gating tech attractive. As much as I would like it to happen, a buyout by JT is pure speculation on my part as I try connecting dots but JT seems like a great possibility: declining combustibles, real cash flow, demonstrated US acquisition appetite, &and a regulatory environment opening up for compliant flavored vape players.
View on StockTwits ↗$CHUC I missed this article in the WSJ from June 2 that British American Tobacco lowered its 2026 cigarette volume forecast (now down ~2.5%, worse than prior guidance) while raising guidance for vapes and nicotine pouches to mid-teens revenue growth. No guarantee this means CHUC gets bought out. But it's encouraging that the space we're in, flavored vapes and alternatives, is exactly where Big Tobacco is being forced to grow as combustibles decline. The macro trend is good for us. $PM $MO $BTI https://www.wsj.com/business/earnings/british-american-tobacco-cuts-cigarette-outlook-but-expects-lift-in-new-category-revenue-31c86c80?mod=Searchresults&pos=5&page=1
View on StockTwits ↗$CHUC @Marci911 You said it perfectly, 500 shares caused a 15% drop. On a company with 295 million shares outstanding. That's 0.00017% of the float moving the price double digits. The bid-ask spread alone (over 7 cents) tells you everything about the liquidity problem on the OTCQB. This is not price discovery. This is manipulation made possible by zero institutional floor, no market makers providing real liquidity, and no analyst coverage anchoring the price to reality. And you're absolutely right, this doesn't happen on Nasdaq or NYSE American. Institutions provide the floor. Market makers tighten the spread. Analysts anchor the price to fundamentals. 500 shares becomes irrelevant noise instead of a 15% move. The vote passed on June 4. The reverse split is authorized, 3:1 to 50:1 at Board's discretion. The mechanism to end this is now in place. The Board just needs to pull the trigger. The lone voices won't just fall silent. They'll disappear entirely. Long $CHUC $MO $BTI
View on StockTwits ↗$BTI $CHUC $MO I think this is a VERY possible scenario. CHUC launches AG with a few of their PMTAs. The FDA could approve those PMTAs so long as AG attached. The FDA coud say we will approve flavor pmta as long as they have AG. So IKE Tech is in play, but Big Tobacco will have to have flavor pmtas in order to sell flavor even if they have AG. What company has a very large PMTA portfolio?
View on StockTwits ↗$CHUC Great article @DonutHole: - "the next few months are likely to yield more PMTA authorizations as FDA has set a precedent and provided a pathway." - the FDA deployed AI (Elsa 4.0) cutting the PMTA backlog by 70% in 2025. - New policy: products within a batch that qualify get authorized immediately without waiting for the entire submission to be reviewed. CHUC has 678 PMTAs filed. Under the old policy you wait for a comprehensive batch review. Under the new policy individual qualifying products get authorized as they clear. - Congress allocated $200M for enforcement and officially urged FDA to complete PMTA reviews promptly. So in the past week, the R/S vote passed, the PMTA pipeline is accelerating, the enforcement crackdown on illegal vapes has been funded and last, but not least, the age-gating pathway has been validated. I hope a R/S is not required but I'm happy management has approval to get us out of the OTCQB where we are not being taken seriously. Long $CHUC $MO $BTI
View on StockTwits ↗$CHUC It’s official. June 4, 2026, all four proposals passed at the Annual Meeting. - Proposal 1: All five directors re-elected - Proposal 2: Auditor ratified - Proposal 3: Reverse split authorized 1-for-3 to 1-for-50 at Board’s sole discretion - Proposal 4: 15 million additional shares added to equity plan The Board now has full authority to execute the reverse split and uplist to NYSE at any time within the next two years. No further shareholder vote required. This is the moment we’ve been working toward. Everything that happened in May: - Operation Red Mist - Makary’s resignation - Glas age-gating validation - Trump demanding faster approvals - Henry confirming “big tobacco suitors are taking note,” - 204% Q1 revenue growth all of it now has a mechanism to reach institutional investors. The OTCQB door is closing. The NYSE door is opening. To everyone who voted YES great work. Long $CHUC $MO $BTI
View on StockTwits ↗$BTI this entire reversal is very bad signal....could be the top for a while.
View on StockTwits ↗$CHUC 21,400 shares traded. Stock down 3.56%. Total dollar volume: ~$5,900. For context: 21,400 shares is 0.0073% of the 295 million shares outstanding. Less than one hundredth of one percent of the float set today’s price. But this works both ways. The same $5,900 that drops it 4% can push it up 4% or more. We’ve seen both this week. - Neither move reflects the fundamentals. - Neither move reflects the regulatory environment. - Neither move reflects Henry’s official shareholder letter confirming “big tobacco suitors are taking note.” This is pure OTCQB mechanics, no institutional floor, no market makers providing real liquidity, no analyst coverage anchoring the price to reality. Tomorrow is June 4. The vote that changes everything. This doesn’t happen on NYSE American. Institutions don’t let $5,900 write the story for a company with 678 PMTAs, FDA-validated age-gating technology, and Big Tobacco watching. If you haven’t voted YES yet, do it tonight. Long $CHUC $MO $BTI
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
Trading at NaN× earnings vs its 14.0× historical median P/E.
Fair value ≈ $-49.60 · price $61.92 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.